Navigation Links
Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
Date:9/14/2007

er, BCBSA

-- Richard Norling, president and chief executive officer, Premier Inc.

-- Terry Kellogg, executive vice president, Blue Cross and Blue Shield of

Alabama

-- Karen Frush, MD, chief patient safety officer, Duke University Health

System

-- Sam Nussbaum, MD, executive vice president and chief medical officer,

WellPoint, Inc.

Building on the momentum of Premier's Hospital Quality Incentive Demonstration (HQID) pay-for-performance project with the Centers for Medicare and Medicaid Services (CMS) and IHI's 5 Million Lives Campaign, Premier and healthcare leaders from across the country recently launched the QUEST project to improve patient safety and quality in the nation's hospitals while safely reducing healthcare costs. Approximately 100 hospitals will participate in QUEST, which will feature an advisory panel that includes BCBSA and CMS.

"The success of the HQID project led us to believe that similar principles -- clearly defined performance measures, incentives for high performance, transparency, sharing of best practices - can accelerate improvement in other aspects of hospital performance," said Richard A. Norling, Premier's president and CEO. "We are thrilled to collaborate with healthcare leaders at IHI, CMS and BCBSA in our efforts to help hospitals reliably deliver the most efficient, effective and caring hospital experience for each patient."

The Pediatric Rapid Response Team at Duke University Health System worked collaboratively with care teams from inpatient areas to develop strategies, implement the rapid response system, and review performance indicators regularly to determine the program's efficacy. Clinical outcomes included a 65 percent relative risk reduction in the number of non-pediatric intensive care unit (PICU) cardiac arrests, a 56 percent reduction in deaths from the non-PICU cardiac arrests, and a 25 percent reduction in non-PICU inpatient deaths.

"Duke Univ
'/>"/>

SOURCE Blue Cross and Blue Shield Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008).../PRNewswire-FirstCall/ - The Westaim Corporation,a...rch 31, 2008, it,recorded a net loss of $6.9 milli...on. In the same quarter last year, the company rec...hare, on revenues of $6.1 million., Income from c...ter,compared to $1.9 million in the same period la...
(Date:5/12/2008)...y 12, 2008) - Beta-blocker drugs may help prevent ...e the risk of death and major stroke, says a major...ious medical journal, The Lancet. , POISE is the...erative cardiac complications. POISE evaluated th...o patients around the time of surgery. , POISE ...
(Date:5/12/2008)... Are ,the Compassionate Heart, of System, WASHI...tment of,Veterans Affairs (VA), the nation,s large...es Week by honoring six of its top professionals.,... world-class health care,system," stated Secretary...deal of our reputation comes from the personal, on...
(Date:5/12/2008)...PRNewswire-FirstCall/ -- PAREXEL International,Cor...be presenting at the,Robert W. Baird 2008 Growth S...el, Senior Vice President and Chief Financial Offi...L at 10:05 a.m. EDT on Thursday, May 15,2008., A...le through the,"Investor Relations Webcasts" secti...
Breaking Medicine News(10 mins):Health News:Westaim announces 2008 first quarter results 2Health News:Westaim announces 2008 first quarter results 3Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 2Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 3Health News:PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference 2
...nt said Tuesday the rate of HIV/AIDS infections ha... a a major challenge in the country. The state-...rate fell from 6.1 percent in 2004 to the current ...ntry's nearly 35 million people. "Of notable sign...
...al Drug Helpline was launched by the Minister for ...lhi today on occasion of International Day Against...t this helpline would come handy to all of us part... She informed that the Ministry of Social Justice ...
...ealed that fruit, yoghurt, citric and soft drinks,...improper consumption and overuse may lead to devas...as tooth erosion, the break down of tooth structur...of acid on the teeth that leads to decay. Early d...
...sumer rights, the conservatives-dominated US Supre...uld be the ultimate fate of President George W. Bu...ppeal raising the issue of whether the medical equ...deral government may be sued under state law by pa...
Other Medicine News:Health News:Toll Free National Drug Helpline Launched 2Health News:Too Much of Acidic Foods can Cause Permanent Damage to Teeth 2Health News:US Supreme Court Could Protect Medical Equipment Manufacturers from Law Suits 2
(Date:5/12/2008)...lts show promising neurological recovery in severe...y patients treated with Cethrin, HOPKINTON, Mass....euticals, Inc. (Nasdaq: ALSE ) today announced 12...trial of Cethrin, a proprietary recombinant,protei...restore motor and,sensory function after spinal co...
(Date:5/12/2008)...LANTA, May 12 /- CryoLife, ... and tissue processing company, today announced,th...ral allograft heart,valve in a patient at the Clev...e Navia, a cardiac surgeon with the Heart and Vasc...od used to process the combination aortic-mitral h...
(Date:5/9/2008)...NGKOK, Thailand, May 9 /PRNewswire-USNewswire/ -- ...y for the Protection of Animals (WSPA),is on stand...e struck,Myanmar to assess and then relieve the su...rs depend on for food and their livelihoods., W...griculture,Organization of the United Nations (FAO...
(Date:5/9/2008)...ATTLE, May 9 /PRNewswire-USNewswire/ -- The risk o...gn prostatic hyperplasia (BPH), can be,reduced by ...intaining a,normal weight and eating a healthy die...ncer Prevention Program at Fred Hutchinson Cancer ...dies that suggest men need not,feel helpless again...
Breaking Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3Animals That Cyclone Survivors Depend on Need Help Now 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 1PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 2PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 3PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 4PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis 1097 5Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 1Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 2Frequently Asked Questions When Considering a Colorectal Cancer Screening Test From the American College of Gastroenterology 3013 3Study Rates Heart Health of Popular Diet Plans 3010 1Study Rates Heart Health of Popular Diet Plans 3010 2Study Rates Heart Health of Popular Diet Plans 3010 3Study Rates Heart Health of Popular Diet Plans 3010 4St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 1St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 2St Davids Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3007 3
...Impact of Pain on Sleep Interference, INDIANAPOLIS... a,pooled analysis of three studies suggest that i...ge, or diabetic peripheral neuropathy,who are tre...in,both average daily pain and night pain severity...rference than in those patients,taking sugar pill....
.../PRNewswire/ -- Bayer HealthCare,Pharmaceuticals a...es with Betaseron(R) (interferon beta-1b), present...s (AAN) 59th Annual Meeting,demonstrating early e...satisfaction with treatment in patients with relap...vely, these studies highlight the important clinic...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
...le pulse oximetry monitoring system compatible wit...nters. Extremely rugged and cost-effective.The BC...ly delivers pulse oximetry wherever spot-checking ...tpatient clinics and hospitals. In fact, its ergon...
The BCI 3180 Pulse Oximeter is a cost-effective, stand-alone monitor that delivers fast, reliable SpO 2 pulse rate and pulse strength measurements of patients from neonate to adult. This AC or batt
...git Finger Oximeter is a Pulse Oximeter and Sensor...e rate and pulse strength measurements on patients...large LED display, one button keypad and auto powe...it ideal for emergency, hospital or clinical envir...
...S. Food and Drug Administration (FDA) has granted ...s (IOL) for cataract patients with and without pre... apodized diffractive technology to give patients ... and distance) that greatly increases their indepe...
Medicine Products: